uniQure NV (QURE)
6.205
-0.54
(-8.07%)
USD |
NASDAQ |
Nov 15, 16:00
6.19
-0.02
(-0.24%)
After-Hours: 20:00
uniQure Revenue (Annual): 15.84M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.84M |
| December 31, 2022 | 106.48M |
| December 31, 2021 | 524.00M |
| December 31, 2020 | 37.51M |
| December 31, 2019 | 7.281M |
| December 31, 2018 | 11.28M |
| Date | Value |
|---|---|
| December 31, 2017 | 13.11M |
| December 31, 2016 | 25.10M |
| December 31, 2015 | 10.58M |
| December 31, 2014 | 6.141M |
| December 31, 2013 | 4.064M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
7.281M
Minimum
2019
524.00M
Maximum
2021
138.22M
Average
37.51M
Median
2020
Revenue (Annual) Benchmarks
| ProQR Therapeutics NV | 7.052M |
| Merus NV | 43.95M |
| argenx SE | 1.226B |
| Pharming Group | 245.32M |
| Pharvaris NV | -- |